Mental Health News and Research

Latest Mental Health News and Research

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

2 Mar 2011

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Thanks in part to a Norwegian research biobank, researchers have generated important new insight into ADHD and how the condition manifests itself. Among other things, they have found that there is some overlap between ADHD and bipolar disorders with regard to rapid mood swings.

2 Mar 2011

Sleep loss have negative impact on neurobehavioral functioning in children with ADHD

A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.

2 Mar 2011

Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest

An experimental drug that targets a brain system that controls inflammation might help preserve neurological function in people who survive sudden cardiac arrest, new research suggests.

2 Mar 2011

New research finds link between genomic variants in neurological processes and autism

New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered.

2 Mar 2011

Study: Happy people tend to live longer and experience better health

A review of more than 160 studies of human and animal subjects has found "clear and compelling evidence" that - all else being equal - happy people tend to live longer and experience better health than their unhappy peers.

1 Mar 2011

FDA approves roflumilast to treat COPD

The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups or worsening of symptoms from severe chronic obstructive pulmonary disease.

1 Mar 2011

High blood pressure medications useful even in those without hypertension: Study

Researchers have studied existing evidence to suggest that people who have had a stroke or a heart attack might benefit from taking blood pressure medications, even if they do not have high blood. They noted that for every 1,000 people taking the drugs in clinical trials, on average 15 fewer died from heart disease than when the patients got dummy treatment. The study however could not explain the cause for this benefit. The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.

1 Mar 2011

Think positive for a healthy heart: Study

Researchers suggest that heart disease patients are more likely to survive if they have a positive outlook. The study was published Feb. 28 in the journal Archives of Internal Medicine.

1 Mar 2011

New drug approved for COPD by the FDA

The U.S. FDA has approved a new treatment for people with worsening symptoms of severe chronic obstructive pulmonary disease (COPD). COPD affects smokers and the elderly and leads to severe difficulty in breathing, chronic cough and excessive mucus production. An exacerbation can last up to several weeks and result in a decline in lung function and increased risk of death, and it may be associated with severe anxiety, the FDA says.

1 Mar 2011

Tenofovir gel more effective than oral tablet for HIV treatment: Study

In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal tissue than did the oral tablet, while, compared to the gel, the tablet used daily was associated with a 20-times higher active drug concentration in blood.

1 Mar 2011

Depression negatively impacts outcomes of care in patients with CRS: New research

Depression is a common problem in patients with chronic rhinosinusitis and negatively impacts patients' symptom burden, ability to function, and quality of life, according to new research published in the March 2011 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2011

Social networking websites can increase risky sexual behaviors in homeless youth: New study

A new UCLA AIDS Institute study suggests that the use of social networking websites by homeless youth can lead to an increase in risky sexual behaviors. But interestingly, homeless kids who used these sites were also more likely to have been tested for sexually transmitted infections and to be better informed about preventing such infections and HIV.

1 Mar 2011

New GuLF STUDY to look at health effects of oil spill on 55,000 cleanup workers, volunteers

A new study that will look at possible health effects of the Gulf of Mexico's Deepwater Horizon oil spill on 55,000 cleanup workers and volunteers begins today in towns across Louisiana, Mississippi, Alabama, and Florida.

1 Mar 2011

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.

28 Feb 2011

Deal to avert gov't shutdown appears within reach

A recent short-term spending plan that emerged from the House Appropriations Committee includes millions of dollars in cuts to federal health programs. Meanwhile, congressional efforts to reach agreement on a long-term spending plan may be getting more complicated.

28 Feb 2011

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

The Republican strategy is to split the vast middle and working classes -- pitting unionized workers against nonunionized, public-sector workers against nonpublic, older workers within sight of Medicare and Social Security against younger workers who don't believe these programs will be there for them and the poor against the working middle class.

28 Feb 2011

Tenofovir gel may help reduce risk of HIV from anal sex

A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel could help reduce the risk of HIV from anal sex, even though the vaginal gel formulation may not be optimal for rectal use.

28 Feb 2011

Endo fourth quarter total revenues increase 31% to $511 million

Endo Pharmaceuticals today reported financial results for the fourth quarter 2010.

28 Feb 2011

Investing in adolescents can help reduce poverty, improve health, UNICEF report says

Additional investment in the world's 1.2 billion adolescents - 88 percent of whom live in the developing world - has the potential to help alleviate inequality and poverty, UNICEF said in its annual State of the World's Children report released on Friday, IRIN reports.

28 Feb 2011

Mental Health News and Research

Latest Mental Health News and Research

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Sleep loss have negative impact on neurobehavioral functioning in children with ADHD

Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest

New research finds link between genomic variants in neurological processes and autism

Study: Happy people tend to live longer and experience better health

FDA approves roflumilast to treat COPD

High blood pressure medications useful even in those without hypertension: Study

Think positive for a healthy heart: Study

New drug approved for COPD by the FDA

Tenofovir gel more effective than oral tablet for HIV treatment: Study

Depression negatively impacts outcomes of care in patients with CRS: New research

Social networking websites can increase risky sexual behaviors in homeless youth: New study

New GuLF STUDY to look at health effects of oil spill on 55,000 cleanup workers, volunteers

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

Deal to avert gov't shutdown appears within reach

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

Tenofovir gel may help reduce risk of HIV from anal sex

Endo fourth quarter total revenues increase 31% to $511 million

Investing in adolescents can help reduce poverty, improve health, UNICEF report says

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Mental Health News and Research

Latest Mental Health News and Research

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in